Lim, A.M.; Baker, B.; Lion, P.; Angel, C.M.; Simmons, J.; Jackson, B.; Magarey, M.; Webb, A.; Nguyen, K.; Hudson, J.;
et al. Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial. Cancers 2025, 17, 1727.
https://doi.org/10.3390/cancers17101727
AMA Style
Lim AM, Baker B, Lion P, Angel CM, Simmons J, Jackson B, Magarey M, Webb A, Nguyen K, Hudson J,
et al. Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial. Cancers. 2025; 17(10):1727.
https://doi.org/10.3390/cancers17101727
Chicago/Turabian Style
Lim, Annette M., Benjamin Baker, Peter Lion, Christopher M. Angel, Jennifer Simmons, Bryce Jackson, Matthew Magarey, Angela Webb, Kevin Nguyen, Jo Hudson,
and et al. 2025. "Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial" Cancers 17, no. 10: 1727.
https://doi.org/10.3390/cancers17101727
APA Style
Lim, A. M., Baker, B., Lion, P., Angel, C. M., Simmons, J., Jackson, B., Magarey, M., Webb, A., Nguyen, K., Hudson, J., Chin, K. Y., Cardin, A., Ravi, R., Morrison, E., Quinn, T., Hunt, I., & Rischin, D.
(2025). Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial. Cancers, 17(10), 1727.
https://doi.org/10.3390/cancers17101727
